Topical steroids are the mainstay of treatment in atopic dermatitis, but 60–80 per cent patients or carers have an aversion to using them due to the potential side‐effects. Here, the authors discuss topical steroid phobia and the importance of communication in its management.
CITATION STYLE
Ponnambath, N. (2014). How to reassure patients with topical steroid phobia. Prescriber, 25(5), 21–23. https://doi.org/10.1002/psb.1172
Mendeley helps you to discover research relevant for your work.